Primary Adrenal Insufficiency during Immune Checkpoint Inhibitor Treatment: Case Reports and Review of the Literature

Carlos Salinas, Alex Renner, Carlos Rojas, Suraj Samtani, Mauricio Burotto*

*Autor correspondiente de este trabajo

Resultado de la investigación: Contribución a una revistaArtículorevisión exhaustiva

5 Citas (Scopus)

Resumen

As the indications and clinical use of immune checkpoint inhibitors increase, it is expected that we will face some of their less frequently reported complications. Primary adrenal insufficiency is one of them, and given its unspecific symptoms and potentially serious consequences, it is important to have a high degree of clinical suspicion. We present 3 cases and a review of the literature concerning its main clinical characteristics, diagnostics, and management.
Idioma originalInglés
Páginas (desde-hasta)621-626
Número de páginas6
PublicaciónCase Reports in Oncology
Volumen13
N.º2
DOI
EstadoPublicada - 2020

Nota bibliográfica

Publisher Copyright:
© 2020 S. Karger AG. All rights reserved.

Palabras clave

  • Immune-related adverse events
  • Ipilimumab
  • Nivolumab
  • Primary adrenal insufficiency

Huella

Profundice en los temas de investigación de 'Primary Adrenal Insufficiency during Immune Checkpoint Inhibitor Treatment: Case Reports and Review of the Literature'. En conjunto forman una huella única.

Citar esto